Kara N. Maxwell
Oncology
3400 Civic Center Boulevard
West Pavilion, 3rd Floor
Philadelphia, PA 19104
West Pavilion, 3rd Floor
Philadelphia, PA 19104
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 141 publications
Genomic Classification to Predict Survival in Metastatic Prostate Cancer: Development of Somatic Tumor Risk Assessment for Overall Survival-Prostate.
Journal: JCO precision oncology
Published: July 15, 2026
The 'Prostate Cancer Screening for People at Genetic Risk of Aggressive Disease' (PATROL) study.
Journal: BJU international
Published: June 10, 2026
Germline polygenic score for prostate cancer aggressiveness.
Journal: medRxiv : the preprint server for health sciences
Published: May 18, 2026
Interference of clonal hematopoiesis in cfDNA liquid biopsy testing and identification of actionable alterations in large diverse cohort of US veterans.
Journal: The oncologist
Published: March 06, 2026
Prevalence of Helicobacter pylori Exposure and Risk Factors Among BRCA1 and BRCA2 Carriers.
Journal: International journal of cancer
Published: March 03, 2026
NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate, Version 2.2026.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: February 11, 2026
A Comparison of Prostate Cancer Incidence and Mortality Rates in the Veterans Affairs Healthcare system and the Surveillance, Epidemiology, and End Results Program.
Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Published: February 10, 2026
The Biology of Hypomorphic TP53 Variants and Implications for Clinical Management.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 21, 2026
Variation at the R181 residue of p53 confers loss of p53 DNA binding cooperativity with the retention of mitochondrial-associated apoptosis.
Journal: Molecular cancer research : MCR
Published: January 06, 2026
Gastric epithelium from BRCA1 and BRCA2 carriers harbors increased double-stranded DNA damage and augmented growth.
Journal: bioRxiv : the preprint server for biology
Published: November 19, 2025
Liquid Biopsy for Cancer Screening in Li-Fraumeni Syndrome: Interest in Clinical Trial and Reported Barriers to Standard-of-Care Screening.
Journal: Cancer prevention research (Philadelphia, Pa.)
Published: October 28, 2025
Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study.
Journal: European urology
Published: October 23, 2025
Last Updated: 09/26/2026